Fig. 3From: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trialParticipant timeline displaying timepoints of interventions and assessments during the 30-day study period. After the end of study (day 30) survival of the study participants will be followed up until day 90. CS, CytoSorbBack to article page